ASCO 2022 Updates in HR+/HER2- eBC
Lecture Summary - ASCO 2022 Optimization of the Duration of Adjuvant Endocrine Therapy in Early Breast Cancer
By
ASCO 2022 Conference Coverage
FEATURING
Barbara Pistilli
By
ASCO 2022 Conference Coverage
FEATURING
Barbara Pistilli
Login to view comments.
Click here to Login
ASCO 2022 Updates in HR+/HER2- eBC